Veru Inc. (NASDAQ:VERU)

Our blog note from 2/10/2012

Company manufactures a female condem .  After 8 quarters of negative EPS growth company appears to be entering a new growth cycle as women become proactive to taking action protecting themselves against STD’s.  The company reported record sales and profit for 1st quarter 2012. Also benefiting from increased product demand from emerging markets and third world nations. Although quarterly results can fluctuate dramatically the company commented that sales and profits will increase significantly in 2012.

To be among the first to receive alerts like this, subscribe to our premium service!

First Quarter 2012 Results

• Net revenues established a new record and increased 136% to $8.6 million, compared with $3.7 million in the three months ended December 31, 2010.
• The Company reported net income of $2.7 million, or $0.09 per diluted share, in the first quarter of FY2012, which represented an increase of 588% when compared with net income of $0.4 million, or $0.01 per diluted share, in the first quarter of FY2011.

O. B. Parrish, Chairman and CEO stated that "I am pleased with the Company's outstanding performance for the quarter. The Company believes the recent orders and record unit sales for the first quarter are indicative of the increasing long-term demand for FC2 as governments, public health agencies, donor groups and women's advocacy organizations seek increased access to effective prevention for women in the global battle against HIV/AIDS and other sexually transmitted infections (STI's). This is a reflection of the fact that HIV/AIDS is now the leading cause of death worldwide among women between 15 and 44 years of age."